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bovine ovarian follicles during atresia
Nicholas Hatzirodos1, Katja Hummitzsch1, Helen F Irving-Rodgers1,2, Margaret L Harland1, Stephanie E Morris1
and Raymond J Rodgers1*Abstract
Background: The major function of the ovary is to produce oocytes for fertilisation. Oocytes mature in follicles
surrounded by nurturing granulosa cells and all are enclosed by a basal lamina. During growth, granulosa cells
replicate and a large fluid-filled cavity (the antrum) develops in the centre. Only follicles that have enlarged to over
10 mm can ovulate in cows. In mammals, the number of primordial follicles far exceeds the numbers that ever
ovulate and atresia or regression of follicles is a mechanism to regulate the number of oocytes ovulated and to
contribute to the timing of ovulation. To better understand the molecular basis of follicular atresia, we undertook
transcriptome profiling of granulosa cells from healthy (n = 10) and atretic (n = 5) bovine follicles at early antral
stages (< 5 mm).
Results: Principal Component Analysis (PCA) and hierarchical classification of the signal intensity plots for the arrays
showed primary clustering into two groups, healthy and atretic. These analyses and size-frequency plots of coefficients
of variation of signal intensities revealed that the healthy follicles were more heterogeneous. Examining the differentially-
expressed genes the most significantly affected functions in atretic follicles were cell death, organ development,
tissue development and embryonic development. The overall processes influenced by transcription factor gene
TP53 were predicted to be activated, whereas those of MYC were inhibited on the basis of known interactions
with the genes in our dataset. The top ranked canonical pathway contained signalling molecules common to
various inflammatory/fibrotic pathways such as the transforming growth factor-β and tumour necrosis factor-α
pathways. The two most significant networks also reflect this pattern of tissue remodelling/fibrosis gene expression.
These networks also contain molecules which are present in the canonical pathways of hepatic fibrosis/hepatic stellate
cell activation and transforming growth factor-β signalling and were up regulated.
Conclusions: Small healthy antral follicles, which have a number of growth outcomes, exhibit greater variability in
gene expression, particularly in genes associated with cell division and other growth-related functions. Atresia, on the
other hand, not only involves cell death but clearly is an active process similar to wound healing.
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The function of the ovary is to produce and release oo-
cytes to be fertilised, leading to the production of off-
spring. Oocytes develop within ovarian follicles which in
most mammals are formed during fetal life. These
primordial follicles consist of an oocyte arrested in mei-
osis, and therefore not capable of mitosis. The oocyte is* Correspondence: ray.rodgers@adelaide.edu.au
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reproduction in any medium, provided the orsurrounded by a single layer of inactive pregranulosa
cells [1]. These primordial follicles comprise the ‘ovarian
reserve’ from which a number of follicles are activated
each day to commence growth and maturation. During
this process of folliculogenesis, the oocyte enlarges sub-
stantially, pregranulosa cells differentiate into granulosa
cells and replicate, and a large fluid-filled antrum
develops in the middle of the follicle [2]. The growth of
antral follicles is largely under the influence of Follicle-
Stimulating Hormone (FSH) [3]. During follicle growth
granulosa cells produce increasingly more of the hor-
mone oestradiol. After the surge release of Luteinisingtral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Expression of selected genes from the microarray
analysis used for validation by immunohistochemistry
Gene
symbol
Log 2 mean signal intensity ± SD† Fold increases
in atretic follicles‡Healthy follicles Atretic follicles
(n = 10) (n = 5)
CDH1 6.5 ± 0.7 8.9 ± 1.4 4.3
COL1A1 7.9 ± 0.3 7.0 ± 0.7 −1.5
COL1A2 6.6 ± 0.2 8.7 ± 1.9 5.3
NID2 5.0 ± 0.6 9.2 ± 1.4 18.4
† SD = standard deviation.
‡ fold change calculated on non-log transformed data.
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results in ovulation of the oocyte, the remaining granu-
losa cells of the follicle wall transform into luteal cells of
the corpus luteum and produce progesterone [4]. Hence
both the numbers and maturation of granulosa cells in
any given follicle are important and both processes are
regulated by gonadotrophic hormones from the anterior
pituitary.
In mammals, the number of primordial follicles far ex-
ceeds the numbers that ovulate over a lifetime. For ex-
ample in humans, millions of primordial follicles are
formed in the fetal gonad but only about 500 will be
ovulated [5]. Since the numbers of follicles at meno-
pause is practically nil [5], the vast majority of follicles
undergo atresia and regress. The incidence of follicular
atresia [6] is a normal process of ovarian function and
its occurrence across species appears to have increased,
with the evolution of viviparity in which a reduced num-
ber of female gametes are required when compared to
mass-spawning species. Atresia in any species can regu-
late the number of oocytes ovulated and contribute to
the timing of ovulation in a reproductive cycle.
The process of atresia in follicles large enough to have
developed an antral cavity is characterised initially by
death of the mural granulosa cells with the presence of
pyknotic nuclei followed by loss of these layers into the
antrum [7]. The entire follicle wall then begins to break-
down at the basal lamina and inflammatory cells migrate
from the surrounding stromal theca layers, phagocytos-
ing remnants of the granulosa cells and eventually the
oocyte. Atresia leads eventually to death of all the granu-
losa cells within a follicle. The cell death processes can
involve apoptosis, necrosis, autophagy and cornification,
and any of the major cell types of the follicle can be in-
volved, depending upon the stage of follicular develop-
ment when atresia occurs [8]. Atresia also involves
active cellular processes including macrophage infiltra-
tion, phagocytosis, migration of fibroblasts from the
theca and the production of collagen. Interestingly, these
are some of the processes also observed in wound heal-
ing [9,10].
We hypothesise that apart from cell death, other sig-
nalling and pathways will be associated with the process
of atresia. Therefore, to advance our knowledge of atre-
sia we undertook transcriptome profiling of granulosa
cells from small antral follicles before and during atresia.
There have been several studies published, which inves-
tigate granulosa gene expression in developing bovine
antral follicles by microarray [11-14]. Evans et al [11] stud-
ied granulosa from small follicles using self–generated
arrays of approximately 1,300 genes. Other studies have
focused on follicles at larger sizes, comparing follicles with
differences in oestradiol production due to selectively ac-
celerated development (dominance). Here we examinedindividual morphologically-classified healthy (n = 10) and
atretic (n = 5) follicles at the small antral stage of less than
5 mm in diameter, prior to size deviation due to dominant
selection. The Bovine Affy arrays we used contain more
than 11,000 annotated genes, thereby expanding the
power to reveal networks and pathways involved in follicle
regression. The healthy follicles were further classified into
two phenotypes based upon the shape of the basally-
situated granulosa cells, as either columnar or rounded
[15]. These follicle types also differ in the quality of their
oocytes when cultured in vitro [16]. The atretic follicles
were of the type called antral atretic [7,8]. This is the clas-
sic type of atresia commonly observed across species in
which the antrally-situated granulosa cells are the first to
undergo cell death.
Results and discussion
In this study we have identified major differences in gene
expression pathways and networks that develop in gran-
ulosa cells of small antral follicles during the process of
atresia. To achieve this, granulosa cells from small
healthy (3.1 ± SEM 0.2 mm diameter; n = 10) and atretic
(4.2 ± 0.5 mm; n = 5) follicles were selected for the
microarray gene expression analysis. To ensure that the
granulosa cells isolated were not contaminated with any
thecal cells, no follicles with more than a 1% level of ex-
pression of CYP17A1 found in thecal samples were in-
cluded. CYP17A1 is expressed exclusively in thecal cells
[17]. We also validated that our microarray analyses
could detect differentially-expressed genes here by im-
munohistochemistry and elsewhere [18] by real time re-
verse transcription polymerase chain reaction (real time
RT-PCR). Table 1 shows the selected genes and their sig-
nal intensities and fold differences between healthy and
atretic follicles. CDH1, the gene for the cell-cell adhesion
molecule E-cadherin, and NID2, the gene for nidogen 2,
were both increased in atretic follicles. By immunohisto-
chemistry, the levels of both E-cadherin (Figure 1A, B)
and nidogen 2 (Figure 1C, D) were elevated in the mem-
brana granulosa of atretic follicles. Collagen type I was also
examined by immunohistochemistry on the basis that
Figure 1 Localisation of E-cadherin, perlecan, nidogen 2 and collagen type I in small healthy and atretic follicles. (A, B) E-cadherin (red)
is restricted to the membrana granulosa and is strongly expressed in atretic follicles. Perlecan (green) marks the follicular and sub-endothelial
basal lamina and is expressed in the cytoplasm of granulosa cells of healthy and atretic follicles. (C, D) Nidogen-2 (red) is localised to the basal
lamina of both follicle types, but is only expressed in the granulosa layer of small atretic follicles. Collagen type I (green) is not localised to the
granulosa cells. It is restricted to the thecal and medullar stroma. The star indicates the granulosa layer. Bar = 50 μm.
Figure 2 Unsupervised PCA of arrays for small healthy (n = 5
rounded phenotypes in yellow and n = 5 columnar phenotypes
in blue) and small atretic (n = 5, in red) follicles. The graph is a
scatter plot of the values for the first (X) and second (Y) principal
components based on the correlation matrix of the total normalised
array intensity data.
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gen type 1 was detected in the membrana granulosa of
healthy or atretic follicles but it was identified in the thecal
layers at higher levels in atretic follicles. Collagen type I
contains both α1 and α2 subunits and whilst COL1A2 was
elevated COL1A1 was not. Thus expression of collagen type
I could not be validated, but both CDH1 and NID2 were.
Statistical analysis of differentially-expressed genes
Small healthy follicles were classified as either columnar
(n = 5) or rounded (n = 5) on the basis of the shape of the
basally-situated granulosa cells [15,16] as described in the
Methods. PCA for the first three components (Figure 2)
and hierarchical clustering (Figure 3) for the total number
of probe sets (n = 24,182) of all arrays in this study were
conducted. Neither of these unsupervised analytical
methods separated the small healthy follicle arrays into
the rounded and columnar groups, and in fact no genes
were shown to be more than 2-fold differentially ex-
pressed between the two subgroups with a Benjamini-
Hochberg False Discovery Rate (FDR) of P < 0.05 by
ANOVA. Therefore, the small healthy follicle arrays were
treated as a single group for further analyses (n = 10) and
compared with the small atretic follicle group.
Before statistical analysis, PCA for all arrays revealed
that the first principal component which accounted for51% of the variation in the data, could separate the
atretic and healthy follicle groups (Figure 2). Hierarch-
ical classification of the signal intensity plot for these ar-
rays similarly also showed primary clustering of the
arrays into these two groups (Figure 3). The numbers of
Figure 3 Unsupervised hierarchical clustering across all probe
sets (n = 24,182) for 15 arrays using the Euclidian dissimilarity
algorithm with the average linkage method in Partek Genomics
Suite. The heatmap represents the distribution of normalised signal
intensity, grouping by pattern similarity for both probe set and array.
(R = rounded and C = columnar phenotypes).
Table 2 Number of probe sets differentially expressed in










P < 0.05 >2 2573 2866 5439
>3 824 771 1595
>4 440 265 705
P < 0.005 >2 2397 2736 5133
>3 801 732 1533
>4 433 257 690
Determined by ANOVA and the step-up Benjamini Hochberg False Discovery
Rate method for multiple corrections using Partek Genomics Suite Software.
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healthy or atretic follicles are shown in Table 2. Follicu-
lar atresia was characterized by considerable change in
the transcriptional processes of the granulosa cells as ex-
pected with over 22% of the total genes on the array be-
ing affected at least 2 fold or more (5,439 from 24,182).
Four hundred and forty probesets were up regulated and
265 were down regulated more than 4 fold in atreticfollicles relative to small healthy follicles. Using thresh-
olds of 3- and 4-fold differential-expression levels with
P < 0.05 and < 0.005 respectively, then 1,595 and 690
differentially-expressed probe sets were identified, re-
spectively (Table 2). The larger dataset (1,595 probe sets)
was tabulated with gene and fold change details added
as Table 3 (up regulated in atretic) and Table 4 (down
regulated) and in Additional file 1: Table S1.
Variability of gene expression between follicles
The PCA indicated that the healthy follicles were a more
heterogeneous group than the atretic follicles and we ex-
amined this further. In other studies examination of the
variably expressed genes has recently been used as a tool
to identify differences in the pathways of different
neurological diseases [19], therefore we applied a similar
approach to our data. The coefficients of variation (SD/
Mean × 100) for the healthy and the atretic follicles of
each probe set were calculated and the size-frequency
distribution plot for healthy and atretic follicles is shown
in Figure 4. The healthy follicles (Figure 4A) show in-
creasing gene variation with increasing fold difference
for the subset of genes which are differentially regulated
between healthy and atretic follicles, which is not seen
in the atretic follicle group (Figure 4B). We investigated
this variation further and identified the most highly vari-
able genes in small healthy follicles. A group of 682 of
the most variable probe sets in small healthy follicles,
which had a coefficient of variation value of > 46.8%, was
assembled and analysed by Ingenuity Pathway Analysis
(IPA) and Gene Ontology (GO) enrichment analysis
(Tables 5 and 6). Cell cycle regulation is the most com-
mon function associated with the highly variable gene
dataset. Thirteen genes were associated with GO terms
for this function and cyclin genes such as CCNB1,
CCNB2 and CDK1 were represented in both analyses
and in the top canonical pathways. The enrichment ana-
lysis produced a number of additional functionally-
related gene groups associated with variable expression.
These categories included; regulation of vascularity,
extracellular matrix, energy metabolism, inflammation,
Table 3 Genes which were up regulated in small atretic follicles with respect to healthy follicles†
Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change
Cell Cycle and DNA replication
CDKN1C 40.2 RGCC 5.1 IFITM3 3.3
MICAL1 8.9 TOP1 5.1 DYNLT3 3.1
CDC37L1 5.9 RAD52 3.5 BAZ1A 3.0
TOPORS 5.7 KLC1 3.4
Cell Death
TNFRSF12A 10.4 *PHLDA1 4.7 TNFRSF25 3.4
CFLAR 6.0 PDCD4 3.9 TNFRSF1A 3.2
TNFRSF6B 5.9 FAIM 3.8 PDCD10 3.1
Cell Morphology
MAP1LC3C 16.7 APBB1IP 4.6 SNTB2 4.0
CAPG 11.1 MAP2 4.5 MTMR3 3.8
TAGLN 10.8 CNN1 4.4 LMNA 3.5
DBNDD2 9.2 AIF1L 4.4 ABLIM1 3.5
NDRG1 9.0 VCL 4.3 FHOD3 3.4
SYNE1 7.6 WASL 4.3 MARCKSL1 3.2
CLDN5 6.3 CDH1 4.3 MAP9 3.2
SVIL 6.1 ACTA2 4.3 MICAL2 3.1
MICALL2 6.1 TAGLN2 4.3 ELMO1 3.1
FILIP1L 5.6 FSCN1 4.2 ELMO2 3.1
ARPC1B 5.5 FNBP1L 4.1 *ARF5 3.1
FERMT2 5.4 TLN1 4.1 TPGS1 3.0
GSN 5.3 ACTN1 4.1 B9D2 3.0
TUBB6 5.1 DSTN 4.0 FBLIM1 3.0
CAV1 4.6 RILPL2 4.0
Cytokines, Hormones and Receptors
PDGFRA 26.5 IGF2R 6.2 CD302 3.7
SCG2 24.4 ELTD1 6.1 JAG1 3.6
CTGF 23.4 TSPO 5.7 IL10RA 3.6
DKK3 17.4 IGFBP6 5.1 PTPRK 3.6
XCL1 16.7 IGF2 5.0 PLXND1 3.6
SPP1 14.1 TGFBR2 5.0 CMTM3 3.5
OLR1 11.7 MIA3 4.6 IL17RA 3.5
MDK 9.9 IFI30 4.5 NR4A2 3.5
IL18 8.9 IGFBP5 4.3 ANGPTL4 3.4
PRICKLE1 8.2 EFNA4 4.2 EFNA5 3.3
BAMBI 7.6 NR2F1 4.1 GPRC5B 3.3
NDP 7.6 ADM 3.9 GPR155 3.3
GNG2 7.3 PLXNB2 3.8 ACVR1 3.1
PLAUR 6.7 *PVRL2 3.8 SCG5 3.1
BMP2 6.6
Directional Cell Growth
SLITRK2 4.3 ROCK2 3.8 ROCK1 3.3
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Table 3 Genes which were up regulated in small atretic follicles with respect to healthy follicles† (Continued)
Extracellular Matrix and Synthesis
*SPOCK2 23.8 TNFAIP6 7.1 COL18A1 4.0
*NID2 18.5 LOXL4 6.5 *FN1 3.9
*LEPREL1 12.8 LUM 6.1 FBN1 3.8
LAMB1 12.0 COL3A1 5.5 COL4A5 3.5
DCN 11.1 COL1A2 5.3 SPON2 3.5
MGP 9.5 PCOLCE2 4.6 SDC4 3.4
SDC2 9.0 COL4A1 4.5 COL12A1 3.4
FBLN2 8.7 AGRN 4.1 COL6A1 3.2
COL5A2 8.3
Intercellular and Cell to Matrix Adhesion
KRT18 62.4 CLDN1 10.2 MAGI3 4.6
KRT8 53.2 CD9 7.1 AMIGO2 4.5
PTX3 24.1 PCDH7 7.0 ANTXR2 3.7
THBS2 23.9 FLNB 6.6 SPARC 3.6
LGALS3 22.9 MAGI1 6.0 CADM1 3.3
*CD24 17.1 VMP1 5.3 JAM3 3.2
CYR61 14.1 CLDN11 4.9 CCDC80 3.0
CALD1 11.6
Ion Transport
KCNMB4 5.7 CACNB3 4.0 KCTD10 3.8
GPM6A 4.8 CLCA4 3.9 SEPP1 3.7
CLIC4 4.5 SCN5A 3.9 KCNJ2 3.7
Protein Trafficking
ANXA1 10.9 SCG3 4.0 PLEKHB2 3.6
GABARAPL1 6.2 CHMP5 3.7 SCAP 3.4
GIT2 4.4 MVP 3.7 PLEKHG2 3.3
SH3RF1 4.0
Proteolysis or Inhibition
TIMP1 68.9 CAST 6.7 CTSZ 3.5
PLAT 26.5 ADAMTS1 6.1 FBXO32 3.3
SERPINE1 19.3 C1S 5.9 TIMP2 3.3
PRSS23 10.9 CTSH 4.7 CTSK 3.2
CSTB 9.3 MMP11 4.4 CTSB 3.2
RELN 7.7 CTSS 4.4 KLHL36 3.2
MMP23B 7.7 CFD 3.8 SERPINB2 3.1
SERPINB8 7.4 PSMB1 3.5 LYZ 3.0
RNA Processing
PRPF38B 7.1 RBM25 3.9 SNRNP200 3.2
RBMS2 6.3 DDX5 3.7 HNRNPH3 3.2
RBM24 4.6 SYNCRIP 3.6 CPEB4 3.2
RBM17 4.5 DDX42 3.6 EBNA1BP2 3.1
TDRD7 4.3 INTS7 3.3 GEMIN8 3.1
REXO2 4.0 CWC22 3.2
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Table 3 Genes which were up regulated in small atretic follicles with respect to healthy follicles† (Continued)
Transcription Regulation
ANKRD1 48.9 TAX1BP3 4.8 LEF1 3.4
FOSL2 11.7 *MLL3 4.7 TGIF1 3.4
EGR1 11.3 MTPN 4.6 MPHOSPH8 3.4
ATF3 9.7 EPAS1 4.6 MORF4L2 3.3
BCL6 8.6 FOXP1 4.5 MAFK 3.3
ATRX 8.4 ING4 4.4 CSRNP1 3.3
ID1 7.4 GTF2F2 4.4 LARP7 3.3
USF1 6.8 SMAD3 4.3 GTF2E2 3.3
KLF6 6.5 STAT3 4.3 GTF2H4 3.3
RBFOX2 6.5 SERTAD1 4.3 BASP1 3.3
JUN 6.4 HHEX 4.2 LEO1 3.3
CEBPD 6.0 ZNF398 4.2 TCF3 3.3
ID3 5.8 HMBOX1 4.0 ZMIZ2 3.2
*TCF7L2 5.8 PDLIM1 3.9 NFKBIA 3.2
HDAC7 5.8 ZFP36L1 3.9 ZC3H8 3.2
NMI 5.7 JUNB 3.9 OSTF1 3.2
SNAI2 5.7 E4F1 3.9 CIR1 3.2
ZNF292 5.7 ZNF281 3.8 ZNHIT3 3.1
LITAF 5.6 FOS 3.7 GPS2 3.1
CITED2 5.6 FHL2 3.7 CSDC2 3.1
CTR9 5.5 CYLD 3.7 KHDRBS1 3.0
*CEBPD 5.4 TRANK1 3.6 ILF3 3.0
KANK2 5.1 FOXO1 3.6 ANKRD10 3.0
NFIL3 5.0 *CPEB2 3.6
JARID2 4.9 SCAND1 3.5
MXI1 4.9 HDAC5 3.5
Translation Regulation
MRPS28 3.6 EIF4G3 3.2 EIF2AK4 3.2
EIF2AK4 3.5
Transport
APOD 37.5 SLC25A29 4.2 RBP1 3.4
STAR 22.5 STAU1 4.1 TCN2 3.4
SLC17A5 9.0 VPS13B 4.1 SLC25A17 3.4
FABP5 8.9 STEAP1 4.0 CYTH3 3.4
A2M 8.1 RABEP1 3.9 SYT11 3.2
NNAT 7.8 *ABCB1 3.8 FABP4 3.1
SLC40A1 7.2 CRABP2 3.7 AP1S2 3.1
VAT1 6.8 STARD3NL 3.7 NPC2 3.0
SLC39A8 5.2 ANKH 3.6 SNX9 3.0
Other Enzymes
*VNN1 15.1 PNMT 4.1 RAB31 3.2
*PDK4 9.7 HSP90AA1 4.0 PTPRN2 3.2
GFPT2 7.8 RAP2C 4.0 RIOK2 3.2
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Table 3 Genes which were up regulated in small atretic follicles with respect to healthy follicles† (Continued)
QSOX1 5.9 SETD7 4.0 RNF20 3.2
DDAH2 5.5 CHST2 4.0 LHFPL2 3.2
GLRX 5.4 SMS 3.8 PTPN21 3.2
PLSCR4 5.4 NT5E 3.8 RAB7A 3.1
ENPP5 4.9 MARCKS 3.7 DDAH1 3.1
PYGL 4.9 GDPD1 3.6 PPIE 3.1
CA2 4.8 DUSP7 3.6 ARF5 3.1
RPIA 4.7 EGLN1 3.5 RBKS 3.1
PELI1 4.7 ZNRF1 3.4 UST 3.1
MYCBP2 4.6 NAGK 3.4 ENO2 3.1
CPT1A 4.5 MGST2 3.4 RNF8 3.1
GEM 4.4 B4GALT5 3.4 PLCL2 3.0
PIGT 4.3 RAB22A 3.3 DPH5 3.0
DUSP1 4.3 ALDH1A1 3.3 IP6K2 3.0
PXDN 4.2
Other Signalling
*RND3 35.7 EFHD2 5.8 SHISA2 3.9
*DCLK1 19.5 JAK1 5.7 RALA 3.9
GAL 10.6 VAV2 5.6 CSNK2A1 3.7
POSTN 9.9 INSIG2 5.4 BMPER 3.7
ARHGEF11 9.9 WDR44 5.0 ARHGAP32 3.5
TP53INP1 8.9 STK17A 5.0 S100A11 3.3
LMTK2 8.1 PTPN5 4.6 UACA 3.2
SH3BP5 7.5 WHSC1L1 4.5 ERBB2 3.2
GIMAP8 7.5 IRAK1BP1 4.4 FYN 3.2
SH3KBP1 7.4 CFH 4.4 CORO1A 3.2
ARHGEF3 7.1 IFITM1 4.3 BCAR1 3.1
RSPO3 7.1 PIK3CA 4.3 DOCK5 3.1
CD200 7.0 DAB2 4.3 PIK3CD 3.1
PLIN2 6.6 CSNK1G2 4.2 STK38L 3.1
PKIB 6.5 MERTK 4.1 MAP2K3 3.1
FBXO33 6.2 RASA2 4.1 TYRO3 3.1





C8orf4 37.2 RCN2 4.4 CBLB 3.6
SATL1 15.2 KIAA1598 4.4 ASCC2 3.5
WDFY4 11.1 FAM126B 4.4 FAM32A 3.5
PLXDC2 9.1 ZNF317 4.2 OCIAD2 3.5
LUC7L3 8.9 C1orf35 4.2 SAFB2 3.5
ZNF462 7.5 RASAL2 4.2 ALKBH4 3.4
NTN4 7.3 AKAP8L 4.1 TSC22D3 3.4
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Table 3 Genes which were up regulated in small atretic follicles with respect to healthy follicles† (Continued)
KIAA0408 7.2 DENND3 4.1 IRGQ 3.4
RSRC2 7.1 C1QTNF6 4.1 AUTS2 3.4
C10orf10 7.0 CCDC85B 4.1 GATSL2 3.4
PHF3 6.4 ARHGEF2 4.0 COMMD4 3.4
SDE2 6.3 MAP1B 4.0 MLLT11 3.3
BTBD3 6.1 C3orf19 4.0 ZFYVE1 3.3
TMEM14A 5.9 CUL9 4.0 PPFIBP1 3.3
ODF2L 5.8 MAP7D1 3.9 FAM129B 3.3
MXRA8 5.8 MTA3 3.9 FLRT2 3.3
GLIPR2 5.6 LIMCH1 3.9 PRRC2C 3.2
NDRG4 5.6 KLHL24 3.9 GPN3 3.2
TMEM176A 5.4 CXorf26 3.9 MESDC1 3.2
MXRA5 5.3 SHF 3.9 ARMCX3 3.2
CRYAB 5.1 YPEL5 3.9 SNN 3.2
C7orf41 4.9 PQLC3 3.9 KIAA0922 3.2
ZNF608 4.9 TMTC2 3.9 TCP11L2 3.2
KLHL28 4.9 HECA 3.8 ANKRD11 3.2
PLEKHO1 4.8 C9orf3 3.8 C1orf212 3.1
TACC2 4.8 LRCH1 3.8 TMEM176B 3.1
GOLPH3L 4.8 DPH3 3.7 SYAP1 3.1
ERRFI1 4.7 CD83 3.7 METRNL 3.1
SRP14 4.7 CTTNBP2NL 3.7 FAM160A2 3.1
ZDHHC23 4.7 TES 3.7 MEF2BNB 3.1
EML1 4.7 GLTSCR2 3.7 C5orf30 3.1
ANXA2 4.7 CLU 3.6 ATG14 3.1
ZNF521 4.6 LHFP 3.6 BOD1L1 3.1
PDLIM4 4.6 PKIG 3.6 DEFB4A 3.0
KIAA0232 4.4 LSG1 3.6 C17orf101 3.0
C12orf75 4.4
Differentially regulated genes (> 3 fold, P < 0.05) were annotated based on the Entrez Gene database. Genes are listed in descending order of fold change within
each functional category.
† Benjamini-Hochberg post-hoc test for multiple corrections following one way ANOVA.
* Indicates genes determined from the Partek analysis based on the Affymetrix annotations which were not assigned identities by IPA.
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http://www.biomedcentral.com/1471-2164/15/40cell migration and MAPK activity. Interestingly, there
were 17 extracellular matrix genes found to be highly
variable across our healthy follicle arrays, and several of
them code for a number of collagen types (1α1, 1α2,
3α1, 4α3, 4α4 and 18). Energy metabolism was identified
as an important process with an association of 13 genes
from this variable group, particularly glucose metabolism
via ISR2, IGFBP2, PDK4 and ASPSCR1. Molecules known
to promote angiogenesis in the ovary such as VEGF and
angiopoietin, and an inhibitor thrombospondin, were also
associated with our variable dataset.
The large variability of gene expression across healthy
follicles is probably not unexpected since small growing
follicles have a number of possible growth trajectories:
1. continued growth to become a dominant follicle, withthe likelihood of a) ovulation or b) atresia, 2. continued
growth as a subordinate follicle with atresia as the ultim-
ate fate or 3. atresia at an earlier stage. Whether this vari-
ability reflects early commitment or predisposition of
follicles to one of the three outcomes, or whether it re-
flects flexibility without a predetermined outcome is not
clear at this stage. However, our identification of the path-
ways and genes involved is an important first step towards
understanding the underlying mechanisms responsible for
the growth and atresia of follicles.
Pathway, network and upstream regulator analyses of
healthy versus atretic follicles
A set of 690 probe sets, which were more than 4-fold
differentially regulated in signal intensity between atretic
Table 4 Genes which were down regulated in small atretic follicles with respect to healthy follicles†
Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change
Cell Cycle
HAUS4 9.7 CASC5 4.1 FAM83D 3.4
KIFC1 7.2 *PTTG1 4.0 CDCA2 3.3
TOP2A 6.3 BUB1 3.9 KIF23 3.3
HJURP 5.6 SKA3 3.9 CENPF 3.3
CDCA8 4.6 TPX2 3.8 MCM10 3.3
MDC1 4.5 SGOL1 3.8 CDCA3 3.3
RAD51AP1 4.5 CDC20 3.8 OIP5 3.2
CENPE 4.5 GINS3 3.7 ASPM 3.2
ANAPC5 4.4 ASF1B 3.7 NCAPH 3.2
NUSAP1 4.3 CDC6 3.7 MAD2L1 3.1
MYO1D 4.3 ERCC6L 3.6 CKAP2 3.1
KLC2 4.3 CCNB1 3.6 *CENPA 3.1
BUB1B 4.2 PRCC 3.5 AURKB 3.0
CNNM2 4.2 CENPN 3.5
Cell Death
TRIB2 6.5 RIPK3 4.8
Cell Morphology
CKAP2L 4.7 SRGN 4.0 MAPT 3.3
PLP1 4.6 HMMR 3.8 PRC1 3.3
JAKMIP1 4.6 RSPH9 3.7 TNNC1 3.2
TMEM138 4.5 SYNPO 3.6 PHACTR1 3.1
ECT2 4.2 LEMD2 3.5 MYO5C 3.0
TMEM216 4.0 CDH26 3.5
Cytokines, Hormones and Receptors
FGFR2 8.4 INHA 3.8 CCR3 3.2
F2RL2 5.9 ADRA1A 3.7 CHRM4 3.2
VEGFA 5.8 IL7 3.6 P2RY10 3.2
RHO 5.8 CD5 3.6 NR5A1 3.2
IL17RE 5.5 GPR128 3.6 OPN1LW 3.2
LTA 4.8 GPR61 3.6 AHR 3.2
IL18R1 4.6 GPR77 3.5 IL20RA 3.2
FSHR 4.4 FGF10 3.4 HTR1D 3.2
HTR2A 4.4 CCL11 3.4 FGFBP1 3.1
AMH 4.2 OPCML 3.4 TSHB 3.1
GPRC5A 4.2 CCL25 3.4 ASGR1 3.1
OPRM1 4.2 CCL28 3.4 HEG1 3.1
INHBA 4.2 FIGF 3.4 IL1A 3.1
NTRK3 4.1 CD72 3.3 IGF1 3.1
FST 4.0 ABP1 3.3 CASR 3.0
FSHB 4.0 EDNRA 3.3 GMFG 3.0
IL21 4.0 ITGB3 3.2 HTR4 3.0
BMP15 3.8 NGFR 3.2
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Table 4 Genes which were down regulated in small atretic follicles with respect to healthy follicles† (Continued)
Directional Cell Growth
FAT1 3.6
Extracellular Matrix and Synthesis
LAMC2 6.4 COL6A6 3.7 COL10A1 3.5
EPYC 4.3 TRAM2 3.6 *AMELX//AMELY 3.3
Intercellular and Cell to Matrix Adhesion
MUC15 5.7 CLDN6 3.8 DSG1 3.1
PRELP 4.5 CD33 3.5 PECAM1 3.1
*MCAM 4.0 SMAGP 3.5 EPDR1 3.1
*GLYCAM1 3.9 *BOLA-DQ2 3.3 CLEC4E 3.0
SELL 3.9 CD96 3.2
Ion Transport
TTYH1 4.8 KCNE1 3.4 SLC25A34 3.1
FXYD7 4.3 P2RX5 3.2 CACNA1D 3.1
KCNJ15 3.5 TRPM6 3.2 *KCNIP2 3.0
Protein Trafficking
INSIG1 3.8 VPS52 3.2
Proteolysis or Inhibition
*PTI 58.8 TROAP 3.5 DBC1 3.2
CPXM2 5.2 MMP7 3.4 TASP1 3.2
TFPI 5.1 ACE2 3.3 PGA5 3.1
PRSS22 4.4 CPB1 3.3 SERPINI2 3.1
CUL7 4.3 SPPL2B 3.2 MMP3 3.0
KLK4 4.1 SPAG5 3.2 TRIM8 3.0
USP28 3.8
RNA Processing
DCP1A 3.6 U2SURP 3.0
Transcription Regulation
ZFHX3 6.3 HAND1 3.8 BCORL1 3.2
HOXB2 4.6 NFE2L2 3.6 NCOA6 3.2
ZNF385A 4.5 SP100 3.6 EHMT2 3.2
CCNT1 4.5 UHRF1 3.5 CC2D1B 3.2
SRCAP 4.3 BCOR 3.5 IRF2BP1 3.2
LDB1 4.2 RFX5 3.4 NSD1 3.1
POLR3D 4.0 NOTCH4 3.4 TFAP2A 3.1
ELK1 4.0 ASB12 3.3 ZBTB4 3.1
VSX1 4.0 NFIA 3.3 POU1F1 3.1
VGLL1 3.8 HOXD9 3.2 ZNF274 3.0
Translation Regulation
YBX2 4.9 EEFSEC 3.3 EEF1A1 3.1
NARS 3.3
Transport
AQP1 7.0 SLC12A8 4.0 SLC8A1 3.4
TRPA1 6.1 SLC5A9 4.0 EPB42 3.4
*ATP10A 6.1 PDYN 4.0 SYNGR3 3.3
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Table 4 Genes which were down regulated in small atretic follicles with respect to healthy follicles† (Continued)
TNPO1 6.0 SLC24A1 4.0 SLC6A9 3.2
ALB 5.7 RHBG 4.0 AP4B1 3.2
SLC27A3 5.5 ATP13A2 3.8 GOSR1 3.2
SLCO2B1 5.1 KIF20A 3.6 ATP4A 3.2
APOB 5.0 STRA6 3.6 PLLP 3.2
MAL2 4.6 CLDN16 3.5 FLVCR2 3.1
SLC4A2 4.5 SLC7A1 3.5 SLC37A2 3.0
ATP2B4 4.4 GC 3.4 SLC13A2 3.0
ABCD1 4.2 ENSA 3.4 SLC38A11 3.0
SLC16A3 4.1
Other Enzymes
CYP19A1 19.8 CYP4F2 4.2 PNLIP 3.4
AOAH 15.1 PDE4D 4.1 PDE6G 3.3
*PDK4 9.7 GPT 4.1 TRNAU1AP 3.3
NOS2 8.8 PDP2 3.9 ALDH1L2 3.3
ISG20 8.4 DBT 3.9 PJA2 3.3
ALG3 7.8 LPO 3.9 WDR46 3.3
CHST8 7.0 ALOX12B 3.8 IPMK 3.2
HMGCS1 6.9 METTL7B 3.7 ST6GAL1 3.2
GCLC 6.9 *IGL@ 3.7 ALG5 3.2
CA14 6.8 *IGHG 3.7 CA5B 3.2
UGT2B17 6.5 ETNK2 3.6 ACAD10 3.2
AKR1C3 5.9 PIPOX 3.6 DIO1 3.2
GYLTL1B 5.7 RNF168 3.6 ACSM1 3.1
SCD 5.6 LHPP 3.6 GSTM4 3.1
GPX3 5.4 CYP21A2 3.6 RSAD2 3.1
CYP2C19 5.2 NQO1 3.6 ACSM2A 3.1
GPX2 5.0 METTL21B 3.5 SH3GL2 3.1
HSD17B1 4.8 GCNT1 3.5 SEPT4 3.1
*FHL3 4.7 LPPR2 3.5 UBE2C 3.1
LPL 4.6 BCAT1 3.5 RBBP8 3.1
PLA2G1B 4.5 BBOX1 3.5 B3GNT3 3.1
PPP3CC 4.5 PNLIPRP2 3.5 DUSP14 3.0
PDE6A 4.4 METTL2A 3.4 GNA14 3.0
FMO2 4.4 P4HA2 3.4 CPS1 3.0
TYRP1 4.3 GALNT13 3.4
CMBL 4.2 DCT 3.4
Other Signalling
IHH 7.1 MAP4K1 4.0 LAT 3.3
HLA-A 6.2 RIC3 3.8 PILRA 3.3
TBKBP1 6.2 CD84 3.8 GPSM3 3.2
*HSPA1A 5.7 SHCBP1 3.6 DNAJB1 3.1
TESPA1 5.4 GUCA1A 3.6 KIR2DL5A 3.1
JAK3 5.1 MTUS1 3.4 PEX11B 3.1
GUCY2F 4.6 DOK2 3.4 UPK1A 3.1
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Table 4 Genes which were down regulated in small atretic follicles with respect to healthy follicles† (Continued)
SKAP1 4.5 RPS6KA4 3.3 LY6G6C 3.1
RASGRP4 4.2 RGS3 3.3 FIGNL1 3.0
BCL9 4.0
Other
CSN2 17.7 EMID1 4.3 GIMAP7 3.5
MZB1 10.1 CYLC1 4.3 GUCA2A 3.4
STAC3 6.8 CCDC159 4.3 PLEKHF2 3.4
CCDC3 6.3 C21orf62 4.2 IFI44L 3.4
C9orf152 5.9 C1orf170 4.2 ODZ3 3.4
AGR2 5.8 APOBEC4 4.2 MICA 3.3
STAC 5.6 VWA8 4.1 TMEM139 3.3
EFHD1 5.5 PEAR1 4.1 UBN2 3.3
MTHFSD 5.4 MPDZ 4.0 C6orf47 3.3
NXPH2 5.4 IFIT2 4.0 Btnl1 3.3
SPEF1 5.3 ELMOD3 4.0 CXorf64 3.3
CRISPLD2 5.2 PLEK 4.0 DENND2D 3.3
KLHL29 5.2 SOWAHA 3.9 CHAC1 3.3
MEX3C 5.0 GCA 3.8 BIRC5 3.2
CAMP 4.7 LY9 3.8 CAPSL 3.2
KIAA0101 4.6 CCDC132 3.7 *RSPH10B 3.2
HRG 4.6 CRP 3.6 ANKRD17 3.1
KLHL33 4.6 C16orf53 3.6 *RNFT1 3.1
CEP85 4.5 HYOU1 3.6 HYDIN 3.1
PTGFRN 4.5 RASGEF1A 3.6 ASPHD1 3.1
TMIGD2 4.5 PIP 3.6 CCDC97 3.0
C6 4.4 OLFML1 3.5 CCDC43 3.0
WDR76 4.4 FAM178A 3.5 *PA1 3.0
MOB3B 4.4 TAGLN3 3.2 MLKL 3.0
RBL2 3.8 TMED6 3.2 WDR87 3.0
† Differentially expressed genes (≥ 3 fold, P < 0.05) as annotated based on the Entrez Gene database and categorised by function using the Benjamini-Hochberg
post-hoc test for multiple corrections following one way ANOVA.
*indicates genes determined from the Partek analysis based on the Affymetrix annotations which were not assigned identities by IPA.
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jected to pathway analyses in IPA. Of these, 456 were
mapped to known identities in the Ingenuity Knowledge
database and only 428 were eligible for network gener-
ation, due to the presence of replicate probe sets with
specificity for the same gene on the chip. This group
contained 288 probe sets which were up regulated in
atretic with respect to healthy follicles and 140 which
were down regulated. The most significantly affected
functions associated with this dataset were found to be
cell death, organ development, tissue development and
embryonic development, which were all predicted to be
negatively regulated in atretic follicles (Table 7). Up-
stream Regulator analysis revealed that the transcription
factor genes TP53, FOXO4 and CEBPB are predicted tobe activated, whereas those of RXRA, HNF1A and MYC
are inhibited on the basis of known interactions with the
genes in our dataset (Table 8). The most significant ca-
nonical pathways represented in our analysis are shown
in Figure 5. The top ranked canonical pathway (Figure 6),
contains signalling molecules from our dataset which are
common to various inflammatory/fibrotic pathways such
as the transforming growth factor-β (TGFβ) (Additional
file 2: Figure S1) and tumour necrosis factor-α (TNFα)
pathways. The two most significant networks (Figure 7A
and 7B) also reflect this pattern of tissue remodelling/fi-
brosis gene expression. These networks also contain
molecules which are present in the canonical pathways
of hepatic fibrosis/hepatic stellate cell activation and
TGFβ signalling and are up regulated in our analysis and
AB
Figure 4 Frequency coefficients of variation (CV) distributions
in selected datasets from healthy follicles (n = 10) in A and
atretic (n = 5) follicles in B. ‘All genes’ include all the probe sets
present on the array (n = 24,128). ‘2 fold’ or ‘3 fold’ or more
represent all genes which were 2 fold or more (n = 5,475) or 3 fold
or more (n = 1,596) differentially-regulated genes between healthy
and atretic follicles using Partek Genomics Suite Software.
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These include genes such as THBS2, PLAT, BAMBI,
TGFBR2, BMP2, SMAD3, FGFR2, PDGFRA and TIMP1.
GO enrichment analyses of this dataset determined
associations by the categories of biological process,
molecular function and cellular component with atre-
sia in granulosa cells from small follicles (Figure 5 and
Additional file 3: Table S2). These analyses revealed
that blood vessel development and cell adhesion pro-
cesses were affected through genes such as CTGF and
VEGFA, and VNN1 and PIK3CA, respectively. The af-
fected products of genes were localised in terms of this
analysis to the extracellular matrix and the genesLAMC2, COL1A2, COL3A1and COL18A1 were found
in this group. Other functionally related genes of inter-
est such as IGF2, IGFBP5 and IGFBP6 indicate that in-
sulin growth factor activity appeared to be modulated
during the atretic process.
Transcriptional processes of atresia
Apoptosis
Apoptosis is believed to be the major process of cell
death occurring in the antral atretic follicle [7,21]. There
was a significant association in our study between atretic
follicles and molecules which are influenced by the p53
transcription factor. p53 is an activator of apoptotic
pathways in response to cell stress and functions by
regulating cell cycle, DNA repair and metabolic genes
[22]. Contrary to expectations, many genes which were
up regulated in atretic follicles in this study are actually
anti-apoptotic or protective against apoptosis such as
CFLAR [23,24], PIK3CA [25,26] and VNN1 [27]. None
of the caspases or Fas genes which are known to be
involved with apoptotic pathways were found to be
differentially expressed to the same extent as those genes
mentioned above. Previous studies in cattle and humans
have focused on antral follicles of a larger size [11,14,28,29],
than those used in this experiment. It is possible that
cell death mechanisms that operate in larger follicles
are different from those at an earlier stage, where cells
are under different hormonal control, LH in addition
to FSH, and in the presence of focimatrix [28]. An al-
ternative theory is that only those granulosa cells in
the atretic follicle with elevated expression of anti-
apoptotic genes are capable of surviving longer during
the process of apoptosis. This theory would fit with the
granulosa stem cell model as proposed previously [30].
This model proposes that different types of granulosa
cells within the same follicle are derived from stem
cells which grow and divide and eventually differenti-
ate into antral, basal and cumulus granulosa cells in
the antral follicle. Hence, at any one time not all gran-
ulosa cells would be equal and some could be more
susceptible to apoptosis than others, as stem cells in
muscle [31], neural [32] and bone marrow [33] are
(reviewed in [34]).
Intercellular junctions
We found increased expression of the claudin tight junc-
tion genes CLDN1, CLDN5 and CLDN11 and the E-
cadherin gene, CDH1, in atretic follicles. The increase in
E-cadherin expression was also verified by immunohisto-
chemistry. Tight junctions act as a critical barrier to the
passage of substances between the vasculature and the
interior lumen of glands [35] and together with gap
junctions help maintain the overall stability of the epi-
thelial layer structure [36]. They are also important for
Table 5 The most variable genes in small healthy follicles mapping to networks and pathways in IPA
Genes mapped from dataset
Symbol Biological process
Network 1 †(Score = 42) PLSCR1, PLSCR4, heparanase, CTSL1, ATP2B1 apoptosis
UHRF1 cell cycle regulation, mitosis
TIMP1, matrix degradation
EGFR, JUNB, FOSL2 differentiation/maturation of
granulosa cell through AP-1




ADM regulation of blood supply
CLDN11 maintenance of epithelial integrity
VARS growth metabolism
AHNAK actin cytoskeleton organisation,
cell polarization
Network 2 †(Score = 42) CCNB1, ESPL1, H1FX, H2AFX, BUB1,NCAPG, NCAPG2, SEPT4,
S100A4, G3BP1
cell cycle regulation, mitosis
PSMD4, PSMD13, UBQLN1, PDIA4, HSP70 protein recycling and folding
PEG3 apoptosis
PRC1 cell migration
Canonical pathways Cell Cycle: G2/M DNA Damage Checkpoint Regulation, Mitotic roles of Polo-Like Kinases P value††
Fisher’s B-H FDR
1 CCNB1,CCNB2,CDK1,GADD45A, RPRM, TOP2A, YWHAG cell cycle regulation, mitosis 3.2 × 10-4 5.8 × 10-2
2 3.9 × 10-4 5.8 × 10-2
3 ATM Signalling
JUN, SMC2, GADD45A, H2AFX, CCNB2, CDK1, CCNB1 response to DNA damage 8.2 × 10-4 8 × 10-2
†The network score is based on the hypergeometric distribution and is calculated with the right-tailed Fisher’s Exact Test. The score is the negative log of this
P value.
†† Significance of association of genes with canonical pathways was determined by a right tailed Fisher’s Exact Test and the Benjamini-Hochberg False Discovery
Rate (B-H FDR) for multiple comparisons. The variability of expression was determined by a frequency distribution of the coefficients of variation for probe sets
across the arrays in the small healthy follicle group. The cut-off chosen was a coefficient of variation of > 46.8% (n = 10 arrays, n = 682 probe sets).
Gene symbols which are underlined indicate those genes which interact with a minimum of 4 other molecules within the dataset.
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[37]. Properly formed tight junctions have not been ob-
served in the membrana granulosa, though they do exist
between Sertoli cells, the analogous cell type in the testis
[38]. Gap junctions are present in the granulosa of several
species with predominant expression of connexins 43 and
37 (reviewed by [39]). E-cadherin is another protein found
at intercellular junctions which is important for cell recog-
nition and adhesion [36], and has been demonstrated in
human ovarian follicles [40]. Claudin 1 gene expression
has previously been shown to be up regulated during
apoptotic insult induced by tamoxifen in some breast
tumour cells [41]. Again it is possible that those granulosa
cells which have increased expression of these intercellular
junction proteins may be able to modulate the effects of
apoptotic mechanisms on the cell by stabilising the overall
membrana granulosa structure.Inflammation/TGFβ signalling/Tissue remodelling
There have been a number of studies examining TGFβ
signalling molecules in follicle development, though not
from the aspect of atresia. This is perhaps surprising
given that follicular atresia necessitates a cyclic process
of tissue remodelling, and the well-known involvement
of the TGFβ superfamily in tissue repair. In both IPA
and GO enrichment analyses, there were a number of
genes found to be associated with inflammatory/TGFβ
signalling fibrosis pathways or processes. When we ex-
amined the hepatic fibrosis signalling pathway in IPA,
with respect to the molecules affected from our dataset,
there was increased expression of TGFBR2 and the
downstream SMAD genes and subsequently COL1A2
and COL3A1. The TGFβ receptor has been localised
immunohistochemically to the granulosa cells of antral
follicles of certain species [42,43], though only in large
Table 6 GO enrichment analysis of the most variable genes in granulosa cells from small healthy follicles using
GOEAST†
Biological process Molecular function Cellular component Symbol Entrez gene name
Regulation of vascularity
Angiogenesis (P = 0.009)
CYR61 cysteine-rich angiogenic inducer
COL18A1 collagen 18
THBS1 thrombospondin 1
CXCR4 chemokine receptor 4
ANGPT2 angiopoietin 2




Insulin-like growth factor binding,
two component sensor activity
microsome ISR2 insulin receptor 2
EGFR epidermal growth factor receptor
HSP90AA1 heat shock protein 90 kDa alpha (cytosolic),
class A member 1
PDK4 pyruvate dehydrogenase kinase, isozyme 4
IGFBP2 insulin-like growth factor binding protein 2
CTGF connective tissue growth factor
CYR61 cysteine-rich angiogenic inducer
MGST1 glutathione transferase 1
CALR calreticulin
PTGES prostaglandin E synthase
PLC4 phospholipase C, beta 4
OPTN optineurin
ASPSCR1 alveolar soft part sarcoma chromosome
region, candidate 1
Cell Cycle






UBE2 ubiquitin conjugating enzyme 2
CDK1 cyclin-dependent kinase 1
NUSAP nucleolar and spindle associated protein 1
SKA1 spindle and kinetochore associated
complex subunit 1
NUP85 nucleoporin 85 kDa
CENPN centromere protein N
CENPO centromere protein O
ZW10 kinetochore associated homolog





organisation (P = 0.01)
Heparin binding, extracellular
matrix binding
Basement membrane COL1A1 collagen type I, alpha 1
COL1A2 collagen type I, alpha 2
COL3A1 collagen type III, alpha 1
COL4A3 collagen type IV, alpha 3
COL4A4 collagen type IV, alpha 4
COL18 collagen type XVIII
LAMB1 laminin, beta 1
VCAN versican
FMOD fibromodulin
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Table 6 GO enrichment analysis of the most variable genes in granulosa cells from small healthy follicles using
GOEAST† (Continued)
ADAMTS1 ADAM metallopeptidase with
thrombospondin type 1 motif, 1
ADAMTS6 ADAM metallopeptidase with
thrombospondin type 1 motif, 6
MMP2 matrix metallopeptidase 2
TIMP1 TIMP metallopeptidase inhibitor 1
OGN osteoinductive factor/osteoglycin
OSF-2 osteoblast-specific factor 2
SPARCL1 SPARC-like 1 (hevin)
ASPN asporin
Inflammation Fibrinogen complex THBS1 thrombospondin 1
NOS biosynthesis (P = 0.044) CALR calreticulin
Antigen processing (P = 0.026) BOLA-A major histocompatibility complex (MHC),
class I, A
TGFβ receptor signalling
pathway (P = 0.05)
BOLA-N MHC class I antigen
Fibrinolysis (P = 0.09)
Cell migration CXCR4 chemokine receptor 4
Axon guidance (P = 0.0008) ABLIM1 actin binding LIM protein 1
COL18 collagen type XVIII
EFNA5 ephrin A5
THBS1 thrombospondin 1
EGFR epidermal growth factor receptor
TDGF teratocarcinoma-derived growth factor 1
F2RL1 coagulation factor II (thrombin)
receptor-like 1
INSR insulin receptor
MAPK activity (P = 0.002) THBS1 thrombospondin 1
TDGF teratocarcinoma-derived growth factor 1
INSR insulin receptor
†The significance of association for the GO enrichment analysis was determined by the Benjamini-Yekuteli FDR method for multiple comparisons. The variability
of expression was determined by a frequency distribution of the coefficients of variation for probe sets across the arrays in the small healthy follicle group. The
cut-off chosen was a coefficient of variation of > 46.8% (n = 10 arrays, n = 682 probe sets).
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teinise. A focus on those genes in our study which are dif-
ferentially expressed in small follicles, and are expressed at
a high level in either the healthy or atretic state, reveals
that the inhibin-activin-follistatin axis was most import-
ant. INHA and INHBA, which encode activins and inhibin,
and FST which produces follistatin, were all down regu-
lated in atretic follicles in our study, which is in agreement
with previously published work, as all are required for
proper development of the follicle through the antral stage
of development [44,45]. BAMBI expression in our atretic
follicles was increased relative to healthy follicles; the
encoded protein is known to bind and inhibit activin and
BMP2 (bone morphogenetic protein-2) [46] thus antago-
nising FSH-induced follicle growth.Anti-mullerian hormone (AMH) expression was also
lower in the atretic follicle. AMH has been shown to
delay recruitment of primary follicles to the next stage
of growth or possibly atresia [47]. Additionally, AMH
has been shown to be up regulated in large dominant
bovine follicles versus subdominant and it probably has
a survival effect [48]. GDF-9 and BMP-15 are growth
factors which have been studied in specific knockouts in
mice or mutations in sheep and are known to be import-
ant for antral follicle growth (reviewed by [49]). BMP15
was up regulated 3 fold in small healthy follicles in our
study, whereas GDF9 was relatively unaffected, the
proteins encoded by these genes are secreted specifically
by the oocyte [50,51] which makes up a small proportion
of the total RNA in our samples, so clearly BMP15











8.31E-04 1.57E-02 −2.907 CAV1, CDKN1C, COL18A1, CYP19A1, CYR61, FST, GADD45A, ING4, JUN,
MMP11, NDRG1, SMAD3, STAR, TGFBR2, TIMP1, VEGFA
Cancer hyperproliferation 5.94E-05 9.22E-03 −2.889 AXL, BCL6, CAV1, CDKN1C, CEBPD, CYP19A1, FGFR2, FST, GPX3, IGF2R,
ING4, MERTK, MGP, MXI1, NOS2, PLAUR, PLP1, POSTN, SERPINE1, SMAD3,
SPP1, STAR, STAT3, TGFBR2, TIMP1, TOP1, VEGFA
Cell Death cell death of
organ
1.32E-10 3.34E-08 −2.868 A2M, AMH, ATF3, AXL, BCL6, BMP2, C8orf4, CAMP, CAST, CCNT1, CD200,
CDKN1C, CFH, CFLAR, CLIC4, CTGF, CYP19A1, CYP2C9, DCN, DUSP1, EGR1,
GAL, GCLC, GLRX, GNG2, GSN, GTF2F2, ID3, IER3, IGF2, IL18, JUN, KRT8,
LGALS3, LTA, MDK, MERTK, MTPN, MZB1, NOS2, NTRK3, OPRM1, PIK3CA,
PIM1, PLAT, PLAUR, PTPN5, RND3, SERPINA3, SERPINE1, SH3BP5, SMAD3,





5.83E-04 1.21E-02 −2.800 AGRN, ANXA1, ANXA2, AXL, C6, CAMP, CD200, CFH, DUSP1, F2RL2,
HDAC7, HLA-A, HRG, IGF2R, IL18, IL18R1, LTA, MERTK, NDRG1, NOS2,
OPRM1, PDGFRA, PELI1, PLAT, PLP1, SMAD3, SPP1, STAT3, TNFRSF12A,
TNFRSF6B, VEGFA, WASL
Cancer hyperplasia 2.82E-04 7.20E-03 −2.753 AXL, CAV1, CDKN1C, CEBPD, CYP19A1, FGFR2, FST, GPX3, IGF2R, ING4,




1.95E-09 3.70E-07 −2.665 ADAMTS1, ALB, AMH, ANKRD1, AQP1, ATF3, ATRX, AXL, BCL6, BMP2,
CAMP, CAV1, CDKN1C, CFLAR, CITED2, CLDN1, CLDN11, COL18A1,
COL1A2, COL3A1, CTGF, CTSH, CYP19A1, CYR61, DCN, EGR1, EPAS1,
ERRFI1, FABP5, FGFR2, FOSL2, FOXP1, FSHB, FST, GAL, HHEX, HRG, ID1,
ID3, IGF2, IGF2R, IGFBP5, IHH, INSIG2, JARID2, JUN, KLF6, KRT18, LAMC2,
LDB1, LGALS3, LTA, MDK, MERTK, MGP, NDP, NOS2, NR2F1, NTRK3,
PDGFRA, PIM1, PLAT, RHO, SERPINE1, SLC40A1, SLC4A2, SMAD3, SNAI2,
STAT3, TACC2, TDRD7, TGFBR2, THBS2, TIMP1, TNFRSF12A, TYRP1, VCL,
VEGFA, YBX2
All predicted to be decreased.
The predicted activation state is inferred from the bias-corrected z-score, (+ = increased, - = decreased). The bias-corrected z-score is computed based on the
proportion of target genes present in the dataset which are directionally regulated as expected according to known associations with functions compiled from
the literature.
The P value of overlap measures the statistical significance of overlap using Fisher’s exact t-test or the Benjamini-Hochberg False Discovery Rate for multiple
comparisons (B-H FDR), between genes from the dataset and those known to be associated with a function.
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http://www.biomedcentral.com/1471-2164/15/40expression was activated but the status of GDF9 was not
apparent. BMPR2 (bone morphogenetic protein receptor-
2) encodes a receptor for GDF-9 and BMP-15 and is
therefore also critical for follicle expansion. There was a
slight increase in BMPR2 in the atretic follicle expression
in our study, however, this was not significant. Expression
of BMP2 was elevated more than 6 fold in atretic follicles
and this member of the BMP family has been implicated
in activation of FSH-induced follicle growth and in sup-
pression of luteinisation in human cultured granulosa
cells [46]. However, this result was demonstrated in cells
obtained from preovulatory follicles and it is unclear
whether BMP-2 plays the same role earlier in follicle
development.
Angiogenesis
VEGFA was down regulated in the atretic follicles and
MDK (midkine; neurite growth-promoting factor 2) and
THBS2 were up regulated in our study. VEGF is a key pro-
angiogenic factor and its expression is known to correlate
with the size of healthy antral follicles [52] and is weaklyexpressed in atretic follicles [53]. Thrombospondins-1
and −2 are anti-angiogenic and are expressed highly dur-
ing tissue remodelling following injury. Thrombospondin-
2 in particular appears during the late proliferative phase
and is expressed during the remodelling period in con-
junction with MMP-2 [54]. Thrombospondin-1 has been
shown to promote follicular atresia in rats [55], and to-
gether with thrombospondin-2 is expressed inversely with
VEGF in a cyclical fashion during folliculogenesis in cows
[52]. MDK is expressed in many tissues throughout em-
bryonic development, and it has been shown to antagonise
VEGF signalling in vitro and in vivo [56]. Atresia in small
antral follicles predictably appears to involve a decrease in
blood vessel formation which agrees with previous data.
Insulin metabolism
We found increased levels of expression of IGF2R, and
the binding protein genes IGFBP5 and IGFBP6 in atretic
follicles with respect to healthy follicles. A number of
studies have determined the importance of insulin-like
growth factor metabolism at antral stages of follicle









Target molecules in dataset
TP53 activated 4.272 5.78E-11 ALB, ANXA1, ANXA2, ARHGEF2, ARPC1B, ATF3, CALD1, CAV1, CFLAR, CLIC4,
CNN1, COL18A1, COL1A2, COL3A1, COL4A1, CTGF, CTSH, CYR61, DKK3,
DUSP1, EGR1, FBLN2, FERMT2, GADD45A, GLRX, GPX3, GSN, HMGCS1, ID1,
ID3, IER3, IFI30, IGF2, IGFBP5, JUN, KRT8, LGALS3, MAP4K1, MMP23B, MPDZ,
NDRG1, NOS2, NR2F1, PCDH7, PDE6A, PGFRA, PHLDA1, PIM1, PLAUR, POSTN,
RAD51AP1, SAT1, SERPINE1, SGK1, SNAI2, SPP1, STAU1, STK17A, TAGLN2,
TGFBR2, THBS2, TOP2A, TP53INP1, VCL, VEGFA
FOXO4 activated 2.203 5.41E-05 BCL6, CTGF, GADD45A, HMGCS1, IER3, SERPINE1, SGK1, VEGFA
CEBPB activated 2.142 1.59E-07 ALB, CEBPD, COL1A2, CPT1A, CSN2, CYP19A1, DAB2, DCN, GADD45A, GLIPR2,
ID1, IFIT, M3, MGP, MMP11, NDRG4, NOS2, PDGFRA, PDK4, PLAUR, SAT1,
SERPINE1, SGK1, SPP1, STAR, TMEM176A, TNFAIP6, TOP1
RXRA inhibited −2.100 3.52E-04 CEBPD, CPT1A, CYP2C9, FABP5, GCLC, GPT, IER3, LPL, MGP, MMP11, OLR1,
PNMT, SAT1, SLC10A2, SPP1, STAR, VEGFA
HNF1A inhibited −2.168 4.07E-01 ALB, BCL6, C1S, CD55, COL3A1, IHH, SERPINE1, SLC10A2, SLC40A1, SLC4A2,
UGT2B4
MYC inhibited −3.197 7.80E-07 ACTN1, ALB, AQP1, BCL6, CALD1, CAST, CAV1, CD9, CEBPD, CFLAR, CLIC4,
COL1A2, COL3A1, COL4A1, CPT1A, CSTB, DSTN, DUSP1, FABP5, FBLN2,
GADD45A, GCLC, GTF2F2, HLA-A, ID1, ID3, IER3, KLF6, LUM, NDRG1, PLAUR,
PLP1, POLR3D, SGK1, SPP1, TAGLN2, TGFBR2, THBS2, TIMP1, TLN1, TSPO, VEGFA
MYCN inhibited −3.202 8.50E-03 ARPC1B, CAV1, CCNT1, CITED2, COL18A1, COL4A1, CTGF, DKK3, FGFR2, HLA-A,
SDC2, SERPINE1, TAGLN
The predicted activation state is inferred from the bias-corrected z-score, (+ = activated, - = inhibited). The bias-corrected z-score is computed based on the
proportion of target genes present in the dataset which are directionally regulated as expected according to known effects of the regulator on the target compiled from
the literature. The P value of overlap measures the statistical significance of overlap using Fisher’s exact t-test, between genes from the dataset and those known to be
acted upon by an upstream regulator.
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promote proliferation and growth of granulosa cells, but
it is specifically bound by IGF-2 receptor which does not
signal by the same pathways as the IGF-1 receptor, but
rather acts as a clearance mechanism for IGF-2 [61].
The IGF binding proteins bind IGF-1 and −2, and thus
locally regulate their bioavailability in the follicle [62].
IGFBP-5 has previously been shown to increase in
atretic follicles in ruminants [63] perhaps due to in-
creased expression and changing levels of degradative
enzymes. Therefore it seems that antral atretic follicles
have reduced IGF signalling contributing to lower prolif-
eration and decreased metabolism by granulosa cells as
has been previously published.
Extracellular matrix and matrix proteases
There are several matrix genes which were differentially
regulated in our arrays in the atretic follicles including
COL1A2, COL3A1, COL4A1, NID2, LAMB1 and LAMC2.
Immunostaining confirmed that nidogen-2 protein was in-
creased in atretic follicles. Collagens type I and IV were
not detectable in the granulosa cells of small follicles at the
small antral stage. Previous immunohistochemical studies
[64,65] found that the composition of the extracellular
matrix did not change, apart from the presence of laminin
α2 in atretic but not healthy follicles, and that laminin β1
expression was very weak or nearly absent in small antral
atretic follicles [66]. Unfortunately, the laminin α2 geneprobe set was not present on the array so this could not
be confirmed by the present analysis. It is well known that
collagens 1 and 3 are synthesised during the tissue remod-
elling phase following inflammation [67]. Lee and Dunbar
showed an increasing accumulation of laminin β1/γ1 in
between granulosa and theca cells in progressively atretic
follicles in the pig [68], although a similar study by our-
selves in bovine follicles did not indicate differences in
laminin β1 in the follicular basement membrane and
membrana granulosa [66]. Recently, laminin γ2 was found
to be secreted by cultured epithelial cells in response to
wounding and may act as a scaffold for cell migration
[69]. The expression of these genes in our current study
probably represents a step in the eventual regression of
the atretic follicle.
Annexin A2 has been shown to be actively involved in
endocytosis and formation of adherens junctions [70].
There is phagocytosis of necrotic cellular debris during
atresia and we observed an up regulation of E-cadherin
expression in the atretic follicular granulosa cells.
Conclusions
Small healthy antral follicles, which can undergo a num-
ber of growth options, exhibit greater variability in gene
expression, particularly in genes associated with cell div-
ision and other growth-related functions. It is clear that
atresia is associated with transcriptional processes such
as the inhibition of blood vessel formation and the
Figure 5 Top canonical pathways mapped in Ingenuity Pathway Analysis (A) and GO terms classified under biological process (B) for a
selected set of genes differentially regulated between healthy and atretic follicles. In A the bar chart on the left represents the percentage
of genes that map to each canonical pathway, showing those which are up regulated (in red) and down regulated (in blue) in atretic with
respect to healthy follicles. The line chart on the right ranks these pathways derived for the same dataset, from the highest to lowest degree of
association based on the value of a right-tailed Fishers exact t test (black), and the Benjamini-Hochberg False Discovery rate test for multiple
comparisons (red) (top to bottom in graph on right). In B the significance of association was determined by the Benjamini-Yuketeli test for
multiple comparisons. The bar chart indicates the percentage of genes that map to a GO term which are differentially regulated (in blue). Only
those significantly enriched GO terms associated with a subset of genes of the most specific function were presented, to avoid terms which were
too general and of limited value.
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the surrounding stromal cells to initiate follicular re-
modelling. Therefore, atresia not only involves changes
in expression of genes associated with cell death but it is




Ovaries were collected at a local abattoir in South
Australia (from non-pregnant Bos taurus cows, within20 min of slaughter and transported to the laboratory
in Hank’s balanced-salt solution with Mg2+ and Ca2+
(HBSS+/+; Sigma-Aldrich, Castle Hill, NSW, Australia)
on ice. The follicles were dissected from each ovary and
the diameter measured. A small piece of the follicle wall,
approximately 100 mm3, was removed and fixed in 2.5%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.25) for
subsequent classification of follicle health status. The
granulosa cells were removed from the remainder of the
follicles by gentle rubbing with a glass Pasteur pipette,
previously modified by heat sealing the tip into a
Figure 6 The hepatic fibrosis/hepatic stellate cell activation canonical pathway in IPA. Interactions between molecules are shown as
explained in the legend, with focus molecules (those from our dataset) highlighted in colour, based on up (red) or down regulation (green) and
increasing colour intensity with degree of fold change.
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granulosa cells was centrifuged at 500 ×g for 7 min at 4°C,
the medium was removed by aspiration and the cells
washed twice in phosphate-buffered saline (PBS), pH 7.4.
Finally the cells were resuspended in RNAlater (Ambion
Life Technologies Australia Pty Ltd., Mulgrave, VIC,
Australia), and stored at −20°C for subsequent RNA isola-
tion and microarray analysis. A total of 10 samples of
small healthy follicles and 5 small atretic follicles, all <
5 mm and from different animals, were used in this study.
Due to limiting RNA, three of the samples from the small
healthy follicles were pools of two follicles each from the
same animal, whereas the rest were all individual follicles.
Histological classification of follicles
Following fixation overnight, the follicle wall portions of
each follicle were rinsed several times with 0.1 M PBS,pH 7.25, post-fixed in 2% (v/v) aqueous osmium tetroxide
for 1 h at 4°C and embedded in epoxy resin as described
previously [71]. For light microscopic examination, 0.5 μm
thick epoxy sections were cut using a glass knife and a
Richert-Jung Ultracut E ultramicrotome (Leica Microsys-
tems Pty Ltd., VIC, Australia), stained with 1% (w/v) aque-
ous methylene blue and examined using an Olympus
BX50 microscope (Olympus Australia Pty Ltd., Mt.
Waverly, VIC, Australia). Healthy and atretic follicles were
identified as described previously [7,8] wherein healthy
follicles had no dead or dying granulosa cells and atretic
follicles had substantial numbers of dead and dying granu-
losa cells. This death in atretic follicles was characterized
by a loss of layers closest to the antrum and numerous
pyknotic nuclei in the remaining antrally-situated layers
[72,73]. The healthy follicle phenotype was sub-classified
into two types, rounded or columnar, based on the shape
Figure 7 Two statistically significant networks (A and B) produced by mapping differentially expressed genes between healthy and
atretic follicles to molecules in the IPA database. The networks are generated in IPA using triangle connectivity based on focus genes (those
present in our dataset) and built according to the number of interactions between a single prospective gene and others in the existing network,
and the number of interactions the prospective gene has outside this network with other genes as determined by IPA [20]. Interactions between
molecules, and the degree and direction of regulation are indicated similarly as in Figure 6 with up (red) or down regulation (green) and
increasing colour intensity with degree of fold change.
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file 4: Figure S2 shows examples of each of these follicle
types.
RNA isolation
Total RNA was extracted from the granulosa cells
using RNeasy mini RNA extraction kits (Qiagen, Hilden,
Germany) and RNAqueous-Micro kit™ (Ambion®/Life
Technologies Australia Pty Ltd., Mulgrave, VIC, Australia).
The concentration of the RNA was determined by spectro-
photometric measurement at 260 nm. For each granulosacell preparation, 5 μg of RNA was treated with DNA-free™
(Ambion Life Technologies). The quality of the RNA was
assessed by electrophoresis using an Agilent 2100 Bioana-
lyser (Agilent Technologies, Santa Clara, CA, USA) and
only that with a RNA integrity number exceeding eight
was accepted for analysis.
Real time reverse transcription polymerase chain reaction
(real time RT-PCR)
Synthesis of cDNA and real time RT-PCR using plasmid
standards were performed as previously [74] and briefly
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scribed with SuperScript® III Transcriptase (Life Tech-
nologies) using random hexamer primers (Geneworks,
Thebarton, SA, Australia) according to the manufacturer’s
instructions. Primer Express software (Life Technologies)
was used to design primers to the bovine sequences of
18S ribosomal RNA and CYP17A1 (Table 9). An ABI
Prism 7000 Sequence Detection System (Life Technolo-
gies) was used for real time reverse transcription RT-PCR
detection with SYBR Green (Eppendorf, Hamburg,
Germany) and 10 pmoles of forward and reverse primers
in a 20 μl reaction. Primer sequences and PCR condi-
tions are shown in Table 9. Plasmid standards were gen-
erated by cloning amplified products into pCR2.1-TOPO
vector (Life Technologies), then transformed into E.coli
strain XL1 Blue (Agilent Technologies) and DNA was
extracted and purified. These DNA standards were
quantitated by absorbance at 260 nm and serially diluted
over three logs then amplified together with the diluted
sample cDNA in the real time reaction to determine
quantities of RNA expressed as fg RNA/ng 18S riboso-
mal RNA.
Microarray profiling
Following confirmation of the quality of RNA and cDNA
synthesis, hybridisations to GeneChip Bovine Genome
Arrays (Affymetrix, CA, USA) and scanning were per-
formed according to Affymetrix protocols at the Austra-
lian Genome Research Facility (AGRF, Walter & Eliza
Hall Institute of Medical Research, Parkville, VIC,
Australia) and the Adelaide Microarray Centre (AMC,
University of Adelaide, SA, Australia). Between 2 to 5 μg
from the small healthy follicles and 250 ng of RNA from
small atretic follicles was used per probe preparation
with the Affymetrix Genechip 3′ IVT Express kit. Both
types of samples followed a similar labelling and hybridisa-
tion procedure as detailed below. First-strand cDNA syn-
thesis was performed using a T7-linked oligo-dT primer,
followed by second strand synthesis. In vitro transcription
reactions were performed in batches to generate biotinyl-
ated cRNA targets, which were subsequently chemically
fragmented at 95°C for 35 min. Ten micrograms of the
fragmented, biotinylated cRNA was hybridised at 45°C
for 16 h to Affymetrix GeneChip Bovine Genome
Arrays, which contain 24,128 probe sets representing
over 23,000 transcripts and variants, including 19,000Table 9 Primers and conditions used for quantitative RT-PCR




reverse cctgtattgttatttttcgtUniGene clusters. The arrays were then washed and
stained with streptavidin-phycoerythrin (final concen-
tration 10 μg/ml). Signal amplification was achieved by
using a biotinylated anti-streptavidin antibody. The
array was then scanned according to the manufacturer’s
instructions. The scanned images were inspected for
the presence of any defect on the array.
Data normalisation and analyses
To minimize discrepancies due to variables such as sample
preparation, hybridisation conditions, staining, or array
lot, the raw expression data were normalised using RMA
background correction (Robust Multi-array Average [75])
with quantile normalisation, log base 2 transformation
and mean probe set summarisation with adjustment for
GC content which were performed in Partek Genomics
Suite Software version 6.5 (Partek Incorporated, St Louis,
MO, USA). All samples sent for analysis passed all quality
controls. The 15 arrays were analysed as part of a larger
set of CEL files (which additionally included samples of
granulosa cell RNA from 4 large follicles as discussed else-
where [18]) uploaded to the Partek GS software program.
Before statistical analysis, the data were first subjected to
PCA [76] and hierarchical clustering analysis to compare
the gene expression patterns of the arrays in terms of our
classification. Hierarchical clustering was performed using
the Euclidian algorithm for dissimilarity with average link-
age. The expression data were analysed by ANOVA using
method of moments estimation [77] with post-hoc step-
up FDR test for multiple comparisons. The fold change in
expression for each gene was based on the non log-
transformed values after correction and normalisation.
These differentially expressed genes were further anno-
tated and classified based on the Gene Ontology (GO)
consortium annotations from the GO Bos taurus database
(2010/02/24) [78] using GOEAST (Gene Ontology Enrich-
ment Analysis Software Toolkit; [79]). Expression data
were also exported to Excel and used to generate size-
frequency distributions of the coefficient of variation for
each probe set for the two sets of follicles, healthy and
atretic. The microarray CEL files, normalised data and ex-
perimental information have been deposited in the Gene
Expression Omnibus (GEO) database under series record
GSE39589.
Pathway analyses of differentially-expressed genes were
conducted using IPA software (Redwood City, CA,nk accession number PCR reaction conditions
NM_174304 2 min 50°C, 10 min 95°C, 40 × cycles
of 15 s 95°C and 60 s 60°C
DQ2224 2 min 50°C, 10 min 95°C, 40 × cycles
of 15 s 95°C and 60 s 60°C
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datasets were overlaid onto a global molecular network
developed from information contained in the Ingenuity
Knowledge Base. Networks of these molecules were then
generated algorithmically based on their connectivity
(Ingenuity Systems, 2005). The network score is based
on the hypergeometric distribution and is calculated
with the right-tailed Fisher’s Exact Test. The score is the
negative log of this P value. Canonical pathway analysis
identified the pathways from the IPA library of canonical
pathways that were most significant to the dataset in
terms of the ratio of the number of molecules that
mapped to the pathway from the dataset and a right-
tailed Fisher’s exact t-test to determine the probability
that the molecules mapped to the pathway by chance
alone. We also used IPA Upstream regulator analysis to
identify upstream transcriptional regulators. Upstream
regulators were predicted using a Fisher’s exact t-test to
determine the probability that genes from the dataset
correspond with targets which are known to be activated
or inhibited by those molecules based on current know-
ledge in the Ingenuity database.
Immunohistochemistry
Follicles from bovine ovaries were collected and em-
bedded in O.C.T. compound (ProSciTech, Thuringowa,
QLD, Australia) and frozen at −80°C. Follicle sections
(7 μm) were cut using a CM1800 Leica cryostat (Adeal
Pty Ltd., Altona North, Vic, Australia), collected on
Superfrost™ glass slides (HD Scientific Supplies, Wetherill
Park, Australia), and stored at −20°C until use. Antigen
localisation was undertaken on 9 small healthy and 7
small atretic follicles, using an indirect immunofluores-
cence method as previously described [80]. Frozen follicle
sections were dried under vacuum for 5 min, fixed for
5 min and rinsed three times for 5 min in hypertonic PBS
(10 mM sodium/potassium phosphate with 0.274 M NaCl,
5 mM KCl, pH 7.2) before treatment with blocking solu-
tion [10% normal donkey serum (Sigma-Aldrich) in anti-
body diluent containing 0.55 M NaCl and 10 mM sodium
phosphate (pH 7.1)] for 30 min at room temperature. The
sections were incubated with primary antibodies overnight
at room temperature. Additional file 5: Table S3 lists the
antibodies used for immunofluorescence and relevant fix-
ation conditions. Sections were also treated with the nu-
clear stain 4′,6′-diamidino-2-phenylindole dihydrochloride
(DAPI) solution (Molecular Probes, Eugene, OR, USA) to
identify cell nuclei. Coverslips were attached with mounting
medium for fluorescence (Dako Corporation, Carpinteria,
CA, USA) and photographed with an Olympus BX51TRF
microscope with an epifluorescence attachment (Olympus
Australia Pty Ltd., Mt Waverley, VIC, Australia) and a Spot
RT digital camera (Diagnostic Instruments Inc Pty Ltd.,
Victora Park, WA, Australia). Negative controls includedno primary antisera and non-immune mouse, rabbit or rat
serum. No staining of ovarian structures was observed with
these controls.
Additional files
Additional file 1: Table S1. Probe sets which were three fold or more
up regulated in granulosa cells of small atretic follicles with respect to
small healthy follicles by ANOVA in Partek, with P < 0.05 (n = 1595), in
alphabetical order. Probe sets which did not have gene assignations are
placed at the end of the list. The P value for multiple corrections was
determined by the step-up FDR method.
Additional file 2: Figure S1. The canonical TGFβ signalling pathway as
presented in IPA showing genes which were 4 fold differentially
expressed with a FDR P < 0.005 between atretic and healthy follicles
from our dataset. Genes which were up regulated in atretic follicles are
indicated in red, and those which were down regulated are green, with
the degree of fold difference commensurate with the colour intensity.
Additional file 3: Table S2. Genes which were differentially expressed
(4 fold, P < 0.005) in atretic follicles with respect to healthy follicles and
associated with significant GO terms after enrichment analysis by GOEAST.
Additional file 4: Figure S2. Histological classification of small antral
follicles. Methylene blue stained semi-thin sections of (A) healthy rounded,
(B) healthy columnar and (C) atretic small antral follicles. Bar = 50 μm.
Additional file 5: Table S3. Primary antibodies, secondary antibodies,
labelling and fixation conditions used for immunohistochemistry for each
antigen. Secondary antibodies used were either biotin-SP-conjugated
AffiniPure donkey-anti-mouse IgG (Cat. no. 715-066-151), followed by
Cy3-conjugated streptavidin (SA-Cy3, Cat. # 016-160-084) or fluorescein/
DTAF-conjugated streptavidin (SA-DTAF, Cat. # 016-010-084), or Cy3-
conjugated AffiniPure donkey-anti-rabbit IgG (Cat. # 711-166-152) or anti-
mouse (Cat. # 715-166-151) or FITC-conjugated AffiniPure donkey-anti-rat
IgG (Cat. # 712-096-153). All secondary antibodies and conjugated streptavidins
were purchased from Jackson ImmunoResearch Laboratories Inc. (West Grove,
PA, USA) and used at 1:100 dilutions.
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